<VariationArchive RecordType="classified" VariationID="1700026" VariationName="NM_000275.3(OCA2):c.2225dup (p.Phe744fs)" VariationType="Duplication" Accession="VCV001700026" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-08-15" MostRecentSubmission="2022-08-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1692422" VariationID="1700026">
      <GeneList>
        <Gene Symbol="OCA2" FullName="OCA2 melanosomal transmembrane protein" GeneID="4948" HGNC_ID="HGNC:8101" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q12-13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27719008" stop="28099315" display_start="27719008" display_stop="28099315" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28000020" stop="28344457" display_start="28000020" display_stop="28344457" Strand="-" />
          </Location>
          <OMIM>611409</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000275.3(OCA2):c.2225dup (p.Phe744fs)</Name>
      <CanonicalSPDI>NC_000015.10:27871172:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>15q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27871172" stop="27871173" display_start="27871172" display_stop="27871173" variantLength="1" positionVCF="27871172" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28116318" stop="28116319" display_start="28116318" display_stop="28116319" variantLength="1" positionVCF="28116318" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>F720fs</ProteinChange>
      <ProteinChange>F744fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.27871173dup" Assembly="GRCh38">
            <Expression>NC_000015.10:g.27871173dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.28116319dup" Assembly="GRCh37">
            <Expression>NC_000015.9:g.28116319dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009846.1" sequenceAccession="NG_009846" sequenceVersion="1" change="g.233140dup">
            <Expression>NG_009846.1:g.233140dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000275.3" sequenceAccession="NM_000275" sequenceVersion="3" change="c.2225dup" MANESelect="true">
            <Expression>NM_000275.3:c.2225dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000266.2" sequenceAccession="NP_000266" sequenceVersion="2" change="p.Phe744fs">
            <Expression>NP_000266.2:p.Phe744fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300984.2" sequenceAccession="NM_001300984" sequenceVersion="2" change="c.2153dup">
            <Expression>NM_001300984.2:c.2153dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287913.1" sequenceAccession="NP_001287913" sequenceVersion="1" change="p.Phe720fs">
            <Expression>NP_001287913.1:p.Phe720fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000275.3" sequenceAccession="NM_000275" sequenceVersion="3" change="c.2225dupT" MANESelect="true">
            <Expression>NM_000275.3:c.2225dupT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2036555943" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000275.3(OCA2):c.2225dup (p.Phe744fs) AND Tyrosinase-positive oculocutaneous albinism" Accession="RCV002274287" Version="1">
        <ClassifiedConditionList TraitSetID="250">
          <ClassifiedCondition DB="MedGen" ID="C0268495">Tyrosinase-positive oculocutaneous albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-15" MostRecentSubmission="2022-08-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="250" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="198" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ALBINISM II</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinase-positive oculocutaneous albinism</ElementValue>
                <XRef ID="Oculocutaneous+albinism+type+2/5317" DB="Genetic Alliance" />
                <XRef ID="26336006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinoidism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type II</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA2</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4038" />
                <XRef ID="4038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37053367</ID>
                <ID Source="BookShelf">NBK590568</ID>
              </Citation>
              <XRef ID="79432" DB="Orphanet" />
              <XRef ID="C0268495" DB="MedGen" />
              <XRef ID="MONDO:0008746" DB="MONDO" />
              <XRef Type="MIM" ID="203200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5006753" SubmissionDate="2022-08-06" DateLastUpdated="2022-08-15" DateCreated="2022-08-15">
        <ClinVarSubmissionID localKey="NM_000275.3:c.2225dupT|OMIM:203200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002558850" DateUpdated="2022-08-15" DateCreated="2022-08-15" Type="SCV" Version="1" SubmitterName="Centre for Human Genetics, University of Kinshasa" OrgID="507951" OrganizationCategory="laboratory" OrgAbbreviation="CHG-DRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This duplication of a Thyrosine at position 2225 of the coding sequence is predicted to shift the reading frame and introduce a premature stop codon 17 codons downstream. This variant is absent from population databases, including gnomAD, has not been submitted to ClinVar before. We identified this variant in a heterozygous state in two patients with Tyrosinase-positive oculocutaneous albinism in the Democratic Republic of Congo (DRC). The two patients were heterozygous for the classic 2.7 deletion in the OCA2 gene. In one patient, segregation analysis showed that the variant was in trans to the deletion. Segregation analysis was not performed in the other patient. This variant was classified as pathogenic according to the ACMG guidelines.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="2" />
            </Sample>
            <Method>
              <TypePlatform>Sanger Sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.3:c.2225dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11905088</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5006753" TraitType="Disease" MappingType="XRef" MappingValue="203200" MappingRef="OMIM">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

